BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12406510)

  • 21. Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
    Pérez JL
    Microbiologia; 1997 Sep; 13(3):343-52. PubMed ID: 9353754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E.
    Ijichi O; Michel D; Mertens T; Miyata K; Eizuru Y
    Antiviral Res; 2002 Feb; 53(2):135-42. PubMed ID: 11750939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.
    Erice A; Gil-Roda C; Pérez JL; Balfour HH; Sannerud KJ; Hanson MN; Boivin G; Chou S
    J Infect Dis; 1997 May; 175(5):1087-92. PubMed ID: 9129070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection.
    Campanini G; Zavattoni M; Cristina E; Gazzolo D; Stronati M; Baldanti F
    J Clin Virol; 2012 May; 54(1):86-8. PubMed ID: 22381918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
    Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
    Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
    O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
    Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation.
    Sanchez Puch SI; Mathet VL; Porta M; Cuestas ML; Oubiña JR; Videla CM; Salomón HE
    Antiviral Res; 2009 Nov; 84(2):194-8. PubMed ID: 19712701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
    Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
    J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance.
    Chou S; Ercolani RJ; Marousek G; Bowlin TL
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3375-9. PubMed ID: 23650173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.
    Sarasini A; Baldanti F; Furione M; Percivalle E; Brerra R; Barbi M; Gerna G
    J Med Virol; 1995 Nov; 47(3):237-44. PubMed ID: 8551275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.
    Prix L; Maierl J; Jahn G; Hamprecht K
    J Clin Virol; 1998 Jul; 11(1):29-37. PubMed ID: 9784141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
    Drew WL; Miner RC; Marousek GI; Chou S
    J Clin Virol; 2006 Oct; 37(2):124-7. PubMed ID: 16962820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.
    Gentry BG; Vollmer LE; Hall ED; Borysko KZ; Zemlicka J; Kamil JP; Drach JC
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4343-8. PubMed ID: 23817384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
    Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
    J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
    Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
    Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
    J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant.
    Faizi Khan R; Mori S; Eizuru Y; Kumura Ishii K; Minamishima Y
    Antiviral Res; 1998 Dec; 40(1-2):95-103. PubMed ID: 9864050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.
    Posthuma CC; van der Beek MT; van der Blij-de Brouwer CS; van der Heiden PL; Marijt EW; Spaan WJ; Claas EC; Nederstigt C; Vossen AC; Snijder EJ; Kroes AC
    J Clin Virol; 2011 May; 51(1):25-30. PubMed ID: 21388868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral drug resistance of human cytomegalovirus.
    Lurain NS; Chou S
    Clin Microbiol Rev; 2010 Oct; 23(4):689-712. PubMed ID: 20930070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.
    Chou S; Bowlin TL
    Antimicrob Agents Chemother; 2011 Jan; 55(1):382-4. PubMed ID: 21041510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.